Erratum: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial (Obstetrical and Gynecological Survey (March 2005) 60 (171-173))

D. M. Harper, E. L. Franco, C. Wheeler, Daron Gale Ferris, D. Jenkins, A. Schuind, T. Zahaf, B. Innis, P. Naud, N. S. De Carvalho, C. M. Roteli-Martins, J. Teixeira, M. M. Blatter, A. P. Korn, W. Quint, G. Dubin

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalObstetrical and Gynecological Survey
Volume60
Issue number7
StatePublished - Jul 1 2005

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., Roteli-Martins, C. M., Teixeira, J., Blatter, M. M., Korn, A. P., Quint, W., & Dubin, G. (2005). Erratum: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial (Obstetrical and Gynecological Survey (March 2005) 60 (171-173)). Obstetrical and Gynecological Survey, 60(7).